Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial

Clinical Endocrinology

Volumn 65, Issue 6, 2006, Pages 737-744

  Heemstra, K A ^a   Smit, J W A ^a   Eustatia Rutten, C F A ^a   Heijboer, A C ^a   Frolich M ^a   Romijn, J A ^a   Corssmit, E P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; PLACEBO; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; LIPID METABOLISM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THYROID CARCINOMA;

ADULT; CARCINOMA; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERTHYROIDISM; INSULIN; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE;

EID: 33751079333     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02660.x     Document Type: Article

References (47)

1. Cavallo-Perin, P., Bruno, A., Boine, L., Cassader, M., Lenti, G. & Pagano, G. (1988) Insulin resistance in Graves' disease: a quantitative in-vivo evaluation. European Journal of Clinical Investigations, 18, 607-613.
2. Gimenez-Palop, O., Gimenez-Perez, G., Mauricio, D., Berlanga, E., Potau, N., Vilardell, C., Arroyo, J., Gonzalez-Clemente, J.M. & Caixas, A. (2005) Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. European Journal of Endocrinology, 153, 73-79.
3. Iglesias, P., Alvarez, F.P., Codoceo, R. & Diez, J.J. (2003) Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clinical Endocrinology, 59, 621-629.
4. Ikeda, T., Fujiyama, K., Hoshino, T., Takeuchi, T., Mashiba, H. & Tominaga, M. (1990) Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients. Metabolism, 39, 633-637.
5. Jenkins, R.C., Valcavi, R., Zini, M., Frasoldati, A., Heller, S.R., Camacho-Hubner, C., Gibson, J.M., Westwood, M. & Ross, R.J. (2000) Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism. Clinical Endocrinology, 52, 187-195.
6. Tosi, F., Moghetti, P., Castello, R., Negri, C., Bonora, E. & Muggeo, M. (1996) Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism. Metabolism, 45, 1029-1033.
7. Yaturu, S., Prado, S. & Grimes, S.R. (2004) Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. Journal of Cell Biochemistry, 93, 491-496.
8. Andersen, O.O., Friis, T. & Ottesen, B. (1977) Glucose tolerance and insulin secretion in hyperthyroidism. Acta Endocrinologica, 84, 576-587.
9. Malaisse, W.J., Malaisse-Lagae, F. & McCraw, E.F. (1967) Effects of thyroid function upon insulin secretion. Diabetes, 16, 643-646.
10. Kabadi, U.M. & Eisenstein, A.B. (1980) Glucose intolerance in hyperthyroidism: role of glucagon. Journal of Clinical Endocrinology and Metabolism, 50, 392-396.
11. Garcia-Sainz, J.A., Litosch, I., Hoffman, B.B., Lefkowitz, R.J. & Fain, J.N. (1981) Effect of thyroid status on alpha- and beta-catecholamine responsiveness of hamster adipocytes. Biochemica Biophysica Acta, 678, 334-341.
12. Cachefo, A., Boucher, P., Vidon, C., Dusserre, E., Diraison, F. & Beylot, M. (2001) Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. Journal of Clinical Endocrinology and Metabolism, 86, 5353-5357.
13. Costantini, F., Pierdomenico, S.D., De Cesare, D., De Remigis, P., Bucciarelli, T., Bittolo-Bon, G., Cazzolato, G., Nubile, G., Guagnano, M.T., Sensi, S., Cuccurullo, F. & Mezzetti, A. (1998) Effect of thyroid function on LDL oxidation. Arteriosclerosis Thrombosis and Vascular Biology, 18, 732-737.
14. Kung, A.W., Pang, R.W., Lauder, I., Lam, K.S. & Janus, E.D. (1995) Changes in serum lipoprotein (a) and lipids during treatment of hyperthyroidism. Clinical Chemistry, 41, 226-231.
15. Mantzoros, C.S., Rosen, H.N., Greenspan, S.L., Flier, J.S. & Moses, A.C. (1997) Short-term hyperthyroidism has no effect on leptin levels in man. Journal of Clinical Endocrinology and Metabolism, 82, 497-499.
16. Sundaram, V., Hanna, A.N., Koneru, L., Newman, H.A. & Falko, J.M. (1997) Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. Journal of Clinical Endocrinology and Metabolism, 82, 3421-3424.
17. Azizi, F., Raiszadeh, F., Solati, M., Etemadi, A., Rahmani, M. & Arabi, M. (2003) Serum paraoxonase 1 activity is decreased in thyroid dysfunction. Journal of Endocrinological Investigations, 26, 703-709.
18. Diekman, M.J., Anghelescu, N., Endert, E., Bakker, O. & Wiersinga, W.M. (2000) Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. Journal of Clinical Endocrinology and Metabolism, 85, 1857-1862.
19. Oge, A., Sozmen, E. & Karaoglu, A.O. (2004) Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism. Endocr Research, 30, 481-489.
20. Faber, J., Perrild, H. & Johansen, J.S. (1990) Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level. Journal of Clinical Endocrinology and Metabolism, 70, 49-55.
21. Greenspan, S.L. & Greenspan, F.S. (1999) The effect of thyroid hormone on skeletal integrity. Annals of Internal Medicine, 130, 750-758.
22. Murphy, E. & Williams, G.R. (2004) The thyroid and the skeleton. Clinical Endocrinology, 61, 285-298.
23. Quan, M.L., Pasieka, J.L. & Rorstad, O. (2002) Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxin: a systematic overview of the literature. Journal of Surgical Oncology, 79, 62-69.
24. Biondi, B., Fazio, S., Carella, C., Sabatini, D., Amato, G., Cittadini, A., Bellastella, A., Lombardi, G. & Sacca, L. (1994) Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxin. Journal of Clinical Endocrinology and Metabolism, 78, 1028-1033.
25. Biondi, B., Palmieri, E.A., Fazio, S., Cosco, C., Nocera, M., Sacca, L., Filetti, S., Lombardi, G. & Perticone, F. (2000) Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism, 85, 4701-4705.
26. Biondi, B., Palmieri, E.A., Lombardi, G. & Fazio, S. (2002) Effects of subclinical thyroid dysfunction on the heart. Annals of Internal Medicine, 137, 904-914.
27. Sgarbi, J.A., Villaca, F.G., Garbeline, B., Villar, H.E. & Romaldini, J.H. (2003) The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. Journal of Clinical Endocrinology and Metabolism, 88, 1672-1677.
28. Smit, J.W., Eustatia-Rutten, C.F., Corssmit, E.P., Pereira, A.M., Frolich, M., Bleeker, G.B., Holman, E.R., van der Wall, E.E., Romijn, J.A. & Bax, J.J. (2005) Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 90, 6041-6047.
29. Yavuz, D.G., Yuksel, M., Deyneli, O., Ozen, Y., Aydin, H. & Akalin, S. (2004) Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clinical Endocrinology, 61, 515-521.
30. Langer, P., Kocan, A., Tajtakova, M., Petrik, J., Koska, J., Huckova, M., Hanzen, E., Ksinantova, L., Radikova, Z., Imrich, R., Trnovec, T., Blazicek, P., Sebokova, E. & Klimes, I. (2003) Thyroid function and cholesterol level: paradoxical findings in large groups of population with high cholesterol food intake. Endocrine Regulation, 37, 175-180.
31. Lee, W.Y., Suh, J.Y., Rhee, E.J., Park, J.S., Sung, K.C. & Kim, S.W. (2004) Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. Archives of Medical Research, 35, 540-545.
32. Franklyn, J.A., Daykin, J., Betteridge, J., Hughes, E.A., Holder, R., Jones, S.R. & Sheppard, M.C. (1993) Thyroxin replacement therapy and circulating lipid concentrations. Clinical Endocrinology, 38, 453-459.
33. Parle, J.V., Franklyn, J.A., Cross, K.W., Jones, S.R. & Sheppard, M.C. (1992) Circulating lipids and minor abnormalities of thyroid function. Clinical Endocrinology, 37, 411-414.
34. Alberti, K.G. & Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Medicine, 15, 539-553.
35. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
36. Matsuda, M. & DeFronzo, R.A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
37. Alssema, M., Dekker, J.M., Nijpels, G., Stehouwer, C.D., Bouter, L.M. & Heine, R.J. (2005) Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study. Diabetes Care, 28, 860-865.
38. Mooy, J.M., Grootenhuis, P.A., de Vries, H., Valkenburg, H.A., Bouter, L.M., Kostense, P.J. & Heine, R.J. (1995) Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care, 18, 1270-1273.
39. Harris, M.I., Flegal, K.M., Cowie, C.C., Eberhardt, M.S., Goldstein, D.E., Little, R.R., Wiedmeyer, H.M. & Byrd-Holt, D.D. (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-94. Diabetes Care, 21, 518-524.
40. Karlander, S.G., Khan, A., Wajngot, A., Torring, O., Vranic, M. & Efendic, S. (1989) Glucose turnover in hyperthyroid patients with normal glucose tolerance. Journal of Clinical Endocrinology and Metabolism, 68, 780-786.
41. Romijn, J.A., Smit, J.W. & Lamberts, S.W. (2003) Intrinsic imperfections of endocrine replacement therapy. European Journal of Endocrinology, 149, 91-97.
42. Lam, K.S., Chan, M.K. & Yeung, R.T. (1986) High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction - effects of treatment. Quarterly Journal of Medicine, 59, 513-521.
43. Raiszadeh, F., Solati, M., Etemadi, A. & Azizi, F. (2004) Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clinical Endocrinology, 60, 75-80.
44. Abrams, J.J., Grundy, S.M. & Ginsberg, H. (1981) Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. Journal of Lipid Research, 22, 307-322.
45. Muller, M.J., Acheson, K.J., Jequier, E. & Burger, A.G. (1990) Thyroid hormone action on lipid metabolism in humans: a role for endogenous insulin. Metabolism, 39, 480-485.
46. Riis, A.L., Hansen, T.K., Moller, N., Weeke, J. & Jorgensen, J.O. (2003) Hyperthyroidism is associated with suppressed circulating ghrelin levels. Journal of Clinical Endocrinology and Metabolism, 88, 853-857.
47. Hsieh, C.J., Wang, P.W., Wang, S.T., Liu, R.T., Tung, S.C., Chien, W.Y., Lu, Y.C., Chen, J.F., Chen, C.H. & Kuo, M.C. (2002) Serum leptin concentrations of patients with sequential thyroid function changes. Clinical Endocrinology, 57, 29-34.